MoAbs against T cells (CD1, CD2, CD3, CD5) were needed to substitute T cell-specific absorbed rabbit antithymocyte sera.'9 The WT1 MoAb (CD7), however, turned out to be a complete substitute for rabbit anti-T but was introduced at a later occasion (after I 983). 
RESULTS

Pretreatment Characteristics
The ( 1 .6%), and 17 (6.9%) could not be classified with certainty.
Remission Induction
Results ofinduction therapy are given in For (Table  4) . For personal use only. on October 3, 2017. by guest www.bloodjournal.org From At 41h years.
tAt 3'h years.
The group of 76 patients ( 
